Clinical Trials Logo
  1. Home
  2. End-Stage Kidney Disease
  3. NCT04669184

Sarcopenia and Physical Performance in Hemodialysis Patients

End Stage Kidney Disease Clinical Trial

Official title:
Assessment of Sarcopenia, Physical Performance and Cognitive Function in Hemodialysis Patients

Clinical Trial Summary

Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of this study was to investigate the relationship between physical performance and sarcopenia, peripheral muscle strength, activities of daily living, cognitive functions, physical activity level, fragility, pain in hemodialysis patients.

Clinical Trial Description

A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabolic processes in chronic kidney disease. Sarcopenia and physical inactivity progress synergistically. Decreased physical performance is associated with sarcopenia. In hemodialysis patients, daily physical activity level and physical performance decrease. Cognitive impairment is common in chronic kidney disease. Uremic toxins can cause a decrease in cognitive function. One of the most important problems associated with hemodialysis is pain and pain negatively affects functional capacity and quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04669184
Study type Observational
Source Hacettepe University
Contact Merve Firat
Phone +903123051576
Email mervefirat@hacettepe.edu.tr
Status Not yet recruiting
Phase
Start date January 1, 2021
Completion date March 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04319185 - Assisted Peritoneal Dialysis: A Feasibility Study N/A
Recruiting NCT06056739 - Alio WEAR Study: Long-term Wear of the Alio Platform N/A
Recruiting NCT05311956 - Pain Reduction Using NEurostimulation Study N/A
Enrolling by invitation NCT05485961 - Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis Phase 2/Phase 3
Completed NCT02939586 - The Effect of Haemodialysis in Sleep Apnoea N/A
Completed NCT00792454 - Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program N/A
Recruiting NCT03586518 - Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Recruiting NCT05642156 - Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis N/A
Not yet recruiting NCT05774392 - An Observational Study of Patients With Chronic Kidney Disease
Completed NCT01877863 - The Effect of Intradialytic Exercise on the Functional Capacity of Hemodialysis Patients N/A
Completed NCT01859871 - Evaluation of a Website on Living Kidney Donation for Hispanics N/A
Completed NCT00649298 - A Clinical Trial of IntensiVE Dialysis Phase 4
Recruiting NCT05836220 - Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 Phase 3
Completed NCT04912024 - Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
Completed NCT01530945 - Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease N/A
Completed NCT04815850 - Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study
Recruiting NCT05738330 - Symptom Monitoring in Hemodialysis N/A
Completed NCT02475551 - Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation Phase 2
Completed NCT00976846 - Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration N/A